For the readers interested in the stock health of Seneca Biopharma Inc. (SNCA). It is currently valued at $1.73. When the transactions were called off in the previous session, Stock hit the highs of $1.92, after setting-off with the price of $1.55. Company’s stock value dipped to $1.51 during the trading on the day. When the trading was stopped its value was $1.46.
Recently in News on February 4, 2021, INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders – GWPH, VIE, FLIR, SNCA. Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:. You can read further details here
Seneca Biopharma Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.9200 on 02/08/21, with the lowest value was $0.8700 for the same time period, recorded on 01/04/21.
Seneca Biopharma Inc. (SNCA) full year performance was 73.00%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Seneca Biopharma Inc. shares are logging -17.62% during the 52-week period from high price, and 246.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.50 and $2.10.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 8882101 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Seneca Biopharma Inc. (SNCA) recorded performance in the market was 96.59%, having the revenues showcasing 212.27% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 29.74M, as it employees total of 5 workers.
Market experts do have their say about Seneca Biopharma Inc. (SNCA)
During the last month, 0 analysts gave the Seneca Biopharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8334, with a change in the price was noted +1.1150. In a similar fashion, Seneca Biopharma Inc. posted a movement of +181.30% for the period of last 100 days, recording 2,216,163 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SNCA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Seneca Biopharma Inc. (SNCA)
Raw Stochastic average of Seneca Biopharma Inc. in the period of last 50 days is set at 85.82%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 75.32%. In the last 20 days, the company’s Stochastic %K was 68.20% and its Stochastic %D was recorded 67.55%.
Bearing in mind the latest performance of Seneca Biopharma Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 96.59%. Additionally, trading for the stock in the period of the last six months notably improved by 103.03%, alongside a boost of 73.00% for the period of the last 12 months. The shares increased approximately by 22.26% in the 7-day charts and went down by 61.68% in the period of the last 30 days. Common stock shares were driven by 212.27% during last recorded quarter.